InnovAge
INNV
#5810
Rank
NZ$1.88 B
Marketcap
NZ$13.88
Share price
11.91%
Change (1 day)
135.08%
Change (1 year)

Earnings for InnovAge (INNV)

Earnings in 2025 (TTM): -NZ$36.61 Million

According to InnovAge's latest financial reports the company's current earnings are NZ$0.88 Billion. In 2024 the company made an earning of -NZ$43.38 Million, an increase over its 2023 earnings that were of -NZ$57.51 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for InnovAge from 2020 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$36.61 Million-15.6%
2024 -NZ$43.38 Million-24.58%
2023 -NZ$57.51 Million-31.82%
2022 -NZ$84.36 Million-681.94%
2021 NZ$14.49 M-388.91%
2020 -NZ$5.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Merck
MRK
NZ$38.34 B-111,088.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Cocrystal Pharma
COCP
-NZ$16.23 Million-53.05%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-NZ$17.09 Million-50.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
NZ$0.85 B-2,563.68%๐Ÿ‡ฎ๐Ÿ‡ช Ireland